Kubota Pharmaceutical will sell specially designed glasses dubbed Kubota Glass, which it claims are able to reverse the effects of myopia.
The glasses shine tiny lights at the retina to simulate short-distance blurring, forcing the user to look further ahead and in doing so taking the pressure of the axial deformation of eyeballs.
Long-term testing is still required to gauge how effective Kubota Glass is at this in detail, but studies so far suggest that they are at least effective at curbing the progression of myopia.
Kubota Glass has been approved as a medical device in Taiwan and the USA.
Kubota Pharmaceutical charges 770,000 yen for a pair of Kubota Glass while offering a 100-percent satisfaction guarantee.
According to 2009 research conducted by Japan's Ministry of Education, Culture, Sports, Science, and Technology, around 25% of first-graders had less than perfect eyesight, with the percentage rising to 50% among sixth-graders.


Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Gold Prices Hold Firm as Traders Watch U.S.-Iran Ceasefire and Trump-Xi Talks
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO
Gold Prices Slip as Strong Dollar and Rising Oil Weigh on Market Sentiment
Oil Prices Rise as Dollar Gains Ahead of Key U.S. Inflation Data
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Trump to Visit China for Key U.S.-China Summit With Xi Jinping
Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone
US Auto Industry Urges Trump to Block Chinese EV Market Access
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes 



